PRDX2 and colorectal carcinoma: Take together, These results showed that in addition to over-expression of PRDX2 in CRC tissues significantly predicted poor DFS and DSS, high PRDX2 expression also was an independent predictor of poor prognosis in stage I-III, early stage (stage I-II) and advanced stage (stage III) patients.